Cure with SR18662 significantly lessens expansion and proliferation of CRC cells. SR18662 exhibits enhanced efficacy in reducing viability of a number of CRC cell traces. Stream cytometry Evaluation following SR18662 cure displays an increase in cells captured in both S or G2/M phases of the cell cycle and an important boost in the amount of apopto